temp_copy

By Mallory Bowers On November 14, the International Neuroethics Society convened for its annual meeting at the AAAS building in Washington, D.C. I had the pleasure of attending and presenting at INS through the generous support of the Emory Neuroethics Program. The society is an interdisciplinary group of scholars - including lawyers, clinicians, researchers, and policy makers - and the 2014 agenda reflected this diversity in expertise. The conference opened with a short talk by Chaka Fattah, the U.S. representative for Pennsylvania’s 2nd congressional district. As a Philadelphia native, I was excited to learn that Congressman Fattah was an architect of the Fattah Neuroscience Initiative , which was an impetus for developing the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Courtesy of Gillian Hue Discussion of the BRAIN initiative continued through the following panels, “The BRAIN Initiative & the Human Brain Project: an Ethical Focus” and “The

By Daniela Ovadia Daniela Ovadia is the co-director of the Neuroscience and Society Lab in the Brain and Behavioral Sciences Department of the University of Pavia and is the scientific director of Agenzia Zoe .   Deep Brain Stimulation (DBS) is one of the oldest neuromodulation techniques; it was approved by the FDA in 1997 for the treatment of essential tremor , and a few years later, in 2002, the indication was extended to the treatment of Parkinson’s disease and dystonia (in 2003). In 2009 a new era for DBS started when the FDA also approved it as a therapy for obsessive-compulsive disorder. Some patients experienced a very good outcome, while others were less lucky and experienced side effects such as cognitive, behavioral or psychosocial impairments. DBS is now a common procedure for the treatment of many motor and behavioral impairments. As certain patients associations and civil liberties groups claimed that psychosurgery was back, and with it the social control on the pat

During the weekend of September 12 th , Georgia State University was home to fascinating conversations between prominent lawyers, neuroscientists, philosophers, and psychologists. The challenging, thought-provoking, and interdisciplinary nature of this forum was condensed within its title: Neurointerventions and the Law: Regulating Human Mental Capacity . Image from AJOB Neuroscience Organized by the Atlanta Neuroethics Consortium (ANEC), the conference sought debate on the legal implications of using modern neuro-interventions. Some of the questions that were raised included, but were not limited to: What mental capacities does one need in order to be eligible for trial? For punishment? For release? For cognitive enhancement? What policies should be in place to control such neuro-interventions? What are the current neuro-interventions used in the courts, and how are they regulated? How should we view the relationship between mental capacity and both moral and legal responsibility?  I

By Stephanie Hare Stephanie Hare is a second-year PhD student studying neuroscience at Georgia State University . She is the recipient of the first 2CI Neuroethics Doctoral Fellowship and has research interests in psychiatry, law and the normative impact of neuroimaging research. You can connect with Steph via email at share1@student.gsu.edu or use her Twitter handle, @NeuroSteph . On September 20, Emory University hosted a book talk and signing with Dr. Heidi Ravven , author of The Self Beyond Itself: An Alternative History of Ethics, the New Brain Sciences and the Myth of Free Will . Dr. Ravven received an unsolicited $500,000 grant from the Ford Foundation to write a book rethinking traditional ethical frameworks and theories of moral agency. As a leading scholar on the work of Baruch Spinoza and Jewish philosophy, Ravven is perfectly situated to recognize socio-cultural assumptions regarding our beliefs about free will and agency, allowing for the consideration of alternati